The NRG Oncology Podcast
Today: #161 in Health & Fitness, Ireland on our combined chart.
Chart positions today · Mexico
Not on the United States charts we track today.
Not on the United Kingdom charts we track today.
Not on the Canada charts we track today.
Not on the Australia charts we track today.
Not on the Germany charts we track today.
Not on the Brazil charts we track today.
Not on the Mexico charts we track today.
Not on the New Zealand charts we track today.
Not on the India charts we track today.
Not on the Japan charts we track today.
Not on the Philippines charts we track today.
Not on the South Africa charts we track today.
If you like The NRG Oncology Podcast, try…
Ranking history · Mexico
Latest episodes
-
NRG-BR002 Published in JCO
October 7, 2026 · 14 minFor Breast Cancer Awareness Month, we discuss the results of the NRG-BR002 in newly oligometastatic breast cancer published in the Journal of Clinical Oncology today.
-
NRG-HN009 p16-Negative Results at ASTRO 2026
September 29, 2026 · 14 minWe discuss the reported results of the NRG-HN009 p16-negative cohort presented at the ASTRO Annual Meeting Late-Breaking Abstract Session.
-
NRG-CC009 and the MAVERICK Study at ASTRO 2026
September 28, 2026 · 22 minWe discuss both the NRG-CC009 study results presented during the 2026 ASTRO Annual Meeting Plenary Session and the MAVERICK study results presented during the Clinical Trials Session.
-
NRG-GI003 Results in the ASTRO 2026 Plenary
September 28, 2026 · 14 minWe discuss the NRG-GI003 results presented during the 2026 ASTRO Annual Meeting Plenary Session.
-
The SPPORT Study Analysis Results at ASTRO 2026
September 27, 2026 · 12 minWe interview Dr. Shang "George" Zhao on the NRG-RTOG 0534 "SPPORT" study results he presented at the 2026 ASTRO Annual Meeting Clinical Trials Session.
Show 7 more episodesShow fewer episodes
-
The NRG-GY036 Trial for Ovarian Cancer Month
September 4, 2026 · 23 minFor the 2026 Ovarian Cancer Month & Gynecologic Cancer Month, we discuss the currently enrolling NRG-GY036 clinical trial comparing 1 vs. 2 years of maintenance olaparib (with or without bevacizumab) for patients with advanced ovarian…
-
NRG-HN016: The "CONCISE" Study for Locoregionally Advanced Head and Neck Cancer Patients that are Unable to Take Cisplatin
August 13, 2026 · 17 minOur co-hosts interview the PI of the active NRG-HN016 (CONCISE) trial, Dr. Loren Mell. The CONCISE study is a randomized phase III trial comparing radiation therapy (RT) plus carboplatin/paclitaxel vs. RT plus cetuximab for patients with…
-
NRG-GU015, the "ARCHER" Study for Muscle Invasive Bladder Cancer
July 30, 2026 · 28 minOur co-hosts welcome Dr. Scott Delacroix and Dr. Himanshu Nagar to discuss bladder cancer, bladder preservation, and the newly activated NRG-GU015 (ARCHER) clinical trial. In this episode, the experts explore who may benefit from…
-
NRG2026 and Glioblastoma Awareness Day Special
July 15, 2026 · 39 minFor Glioblastoma Awareness Day we discuss the NRG-CC017 study of TMPRT + Temozolomide for glioblastoma with PI, Dr. Huang. We also discuss the challenges faced by larger institutions with Dr. Abraham.
-
Uterine Cancer Awareness Month 2026
June 23, 2026 · 50 minThis special Uterine Cancer Month episode includes three different perspectives in Uterine Cancer research. First we interview uterine and ovarian cancer survivor, NRG PAC Member, and Uterine Corpus Subcommittee Patient Advocate, Anna…
-
Prostate Cancer Analysis and Translational Science from ASCO 2026
May 30, 2026 · 30 minIn this episode, we discuss the results of the combined analysis of the prostate cancer studies RTOG 9202, 9413, 9902, and 0521 as well as learn more about translational science at NRG.
-
NRG-GY018 Mature Results from ASCO 2026
May 29, 2026 · 18 minOur Podcast Co-Hosts interview NRG-GY018 study PI, Dr. Ramez Eskander on the reported mature results of the study in advanced or recurrent endometrial cancer at ASCO 2026.